A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

Clinical trial NCT00546715 · COMPLETED

Trial details

NCT number: NCT00546715
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2007-11-01
Primary completion: 2008-05-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.